newsfilter
← Latest News
ACCESS Newswire·

MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain

MIAMI, FL / ACCESS Newswire / March 13, 2025 / MIRA Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today